| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.05 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.06 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |